SCHEMBL9708066

SCHEMBL9708066

Cn1c(=O)n(-c2ccccc2)c(=O)c2c1nc(C1CCCCC1)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
TSHR P16473 4/20 0.41
MAPK1 P28482 3/20 0.41
HSD17B10 Q99714 3/20 0.41
TP53 P04637 2/20 0.41
AGTR1 P30556 4/20 0.40
AGTR2 P50052 4/20 0.40
NPSR1 Q6W5P4 2/20 0.39
POLB P06746 1/20 0.39
BLM P54132 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
DRD1 P21728 2/20 0.38
DRD5 P21918 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RECQL P46063 1/20 0.38
DPP4 P27487 1/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707343 0.94 KMT2A (0.44) KMT2ATSHRMAPK1HSD17B10TP53
SCHEMBL9707509 0.93 AGTR1 (0.42) KMT2AMAPK1AGTR1AGTR2NPSR1
SCHEMBL9707759 0.92 ADORA3 (0.44) KMT2AAGTR1AGTR2
SCHEMBL9708520 0.91 TSHR (0.48) KMT2ATSHRMAPK1HSD17B10TP53
SCHEMBL9707954 0.90 KMT2A (0.42) KMT2ATSHRMAPK1HSD17B10TP53
SCHEMBL9707442 0.90 KMT2A (0.41) KMT2AMAPK1AGTR1AGTR2NPSR1
SCHEMBL9708163 0.90 KMT2A (0.40) KMT2AMAPK1AGTR1AGTR2NPSR1
SCHEMBL9707890 0.90 PDE5A (0.41) KMT2AAGTR1AGTR2ALDH1A1LMNA
SCHEMBL9708135 0.89 KMT2A (0.43) KMT2ATSHRMAPK1HSD17B10TP53
SCHEMBL9708192 0.89 ADORA3 (0.44) KMT2AAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed